(IQT-NYC.Online) Shahar Keinan, CEO, Polaris Quantum Biotech; has agreed to speak on Panel 3: “Quantum Computing and the Design of New Drugs and Materials” at 2:40 pm on May 20 at Inside Quantum Technology Online, NYC.
Dr. Shahar Keinan is the CEO & co-founder of POLARIS Quantum Biotech. She has over 20 years of extensive experience in the field of computational and theoretical chemistry and published over 50 peer-reviewed manuscripts in the fields of in-silico drug design and discovery, as well as molecular materials design and computational methods development. Shahar has received a Ph.D. in theoretical chemistry from The Hebrew University of Jerusalem, after which she moved to Northwestern University and Duke University for a post-doc positions. Previously she was CSO of Cloud Pharmaceuticals and has been instrumental in the development of the Quantum Molecular Design process since its inception at Duke University, and has pioneered the use of Inverse Design algorithms to optimize electro-optical materials and small molecule drugs.
Vertical FOCUS DAY Schedule
(Exclusive Sponsorships available for each vertical, apply here)
May 17 Morning — Quantum Computers + Quantum Processors
May 17 Afternoon — Quantum Safe (QKD + QRNGs + PQC)
May 18 Morning — Quantum Sensors
May 18 Afternoon— Quantum Materials and Components
May 19 Morning — Quantum Clouds and Service Providers
May 19 Afternoon — The Quantum Internet
May 20 Morning — Quantum Policy and Funding
May 20 Afternoon — Quantum End Users
Register early and save.
Connect with IQT via:
LinkedIn: Inside Quantum Technology